Bookmark
Forward
QuickView for Oxandrolone (compound)
PubChem
| Name: | Oxandrolone |
|---|---|
| PubChem Compound ID: | 249098 |
| Description: | A synthetic hormone with anabolic and androgenic properties. |
| Molecular formula: | C19H30O3 |
| Molecular weight: | 306.44 g/mol |
| Synonyms: |
SC 11585; 8075 C. B.; Protivar; Vasorome; 2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5.alpha.,17.beta.)-; Lonavar; Oxandrolone; 1H-Benz[e]indene-7-acetic acid, dodecahydro-3-hydroxy-6-(hydroxymethyl)-3,3a,6-trimethyl-, .delta.-lactone; Anavar; 17-.beta.-hydroxy-17-methyl-2-oxa-androstan-3-one.
show more » |
DrugBank
Identification
| Name: | Oxandrolone |
|---|---|
| Name (isomeric): | DB00621 |
| Drug Type: | small molecule |
| Description: | A synthetic hormone with anabolic and androgenic properties. |
| Synonyms: |
Ossandrolone [DCIT]; Oxandrolona [INN-Spanish]; Oxandrolonum [INN-Latin]
|
| Brand: | Provitar, Lonavar, Vasorome, Oxandrin, Anavar, Protivar |
| Category: | Anabolic Agents, Androgens |
| CAS number: | 53-39-4 |
Pharmacology
| Indication: | Use to promote weight gain after weight loss following extensive surgery. |
|---|---|
| Pharmacology: |
Oxandrolone is an anabolic steroids indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in some patients who without definite pathophysiologic reasons fail to gain or to maintain normal weight, to offset the protein catabolism associated with prolonged admin...
show more » |
| Mechanism of Action: | Oxandrolones interact with androgen receptors in target tissues. |
| Biotransformation: | Renal |
| Half Life: | 0.55 hours (1st phage), 9 hours (2nd phase) |
| Toxicity: | The oral LD50 of oxandrolone in mice and dogs is greater than 5,000 mg/kg. |
| Affected organisms: | Humans and other mammals |
Interactions
| Drug interaction: |
|
|---|
Targets
